Related topics

Intercept: 4Q Earnings Snapshot

February 25, 2020 GMT

NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Tuesday reported a loss of $98.2 million in its fourth quarter.

The New York-based company said it had a loss of $2.99 per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.56 per share.

The drugmaker posted revenue of $71.5 million in the period, which beat Street forecasts. Nine analysts surveyed by Zacks expected $68.5 million.

For the year, the company reported that its loss widened to $344.7 million, or $10.89 per share. Revenue was reported as $252 million.

Intercept shares have dropped 27% since the beginning of the year. The stock has declined almost 3% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT